home / stock / coll / coll news


COLL News and Press, Collegium Pharmaceutical Inc. From 11/04/21

Stock Information

Company Name: Collegium Pharmaceutical Inc.
Stock Symbol: COLL
Market: NASDAQ
Website: collegiumpharma.com

Menu

COLL COLL Quote COLL Short COLL News COLL Articles COLL Message Board
Get COLL Alerts

News, Short Squeeze, Breakout and More Instantly...

COLL - Collegium Reports Third Quarter Fiscal 2021 Results

- Board of Directors Has Authorized $25 Million Accelerated Share Repurchase Program - - Net Income of $8.0 Million and Adjusted EBITDA of $37.3 Million - - Full-Year 2021 Guidance Updated - - Conference Call Scheduled for Today at 4:30 p.m. ET - STOUGHTON, Mass., ...

COLL - Collegium to Host Conference Call to Discuss Third Quarter 2021 Financial Results and Provide Corporate Update

STOUGHTON, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, announced today that the Company will host a conference call and live webcast on Thursday, ...

COLL - IBB: Healthcare Dashboard For October

A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. Focus on IBB. A list of cheap stocks. For further details see: IBB: Healthcare Dashboard For October

COLL - Sizing Up Collegium Pharmaceuticals

Today, we revisit Collegium Pharmaceuticals for the first time since March of last year. The company is doing a good job of reducing debt and recently announced a substantial stock buyback program. A full investment analysis follows in the paragraphs below. For further detai...

COLL - Collegium Announces Four Posters Presented at PAINWeek 2021 National Conference

STOUGHTON, Mass., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that four poster presentations highlighting data regarding its product por...

COLL - IDNA: Healthcare Dashboard For September

A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. Focus on IDNA. A list of cheap stocks. For further details see: IDNA: Healthcare Dashboard For September

COLL - Hot Stocks: Chinese EV stocks weighed down by regulatory worries; EPIX, MCW decline; COLL, HHR advance

Worries about regulation have swirled lately around both Big Tech and Chinese stocks. These conspired to drag down a specific segment of the Chinese tech market on Monday, as China-based electric vehicle stocks took a tumble. XPeng (NYSE:XPEV), Li Auto (NASDAQ:LI) and NIO (NYSE:NIO) all lost ...

COLL - ASRT, GOCO, AEYE among mid-day movers

Gainers: NanoVibronix (NASDAQ:NAOV) +47%. Enlivex Therapeutics (NASDAQ:ENLV) +20%. GoHealth (NASDAQ:GOCO) +16%. Travere Therapeutics (NASDAQ:TVTX) +16%. Collegium Pharmaceutical (NASDAQ:COLL) +16%. Auddia (NASDAQ:AUUD) +15%. AudioEye (NASDAQ:AEYE) +14%. Cohen & Company (NYSE:COHN) +14%. F...

COLL - NanoVibronix, Nymox Pharmaceutical leads healthcare gainers; Sesen Bio, ESSA Pharma among major losers

Gainers: NanoVibronix NAOV +44%, Nymox Pharmaceutical (NASDAQ:NYMX) +21%, Travere Therapeutics TVTX +20%, Enlivex Therapeutics ENLV +15%, Collegium Pharmaceutical COLL +11%. Losers: Sesen Bio SESN -35%, ESSA Pharma EPIX -32...

COLL - Collegium Announces $100 Million Share Repurchase Program

STOUGHTON, Mass., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that its Board of Directors has authorized the repurchase of up to $100 mil...

Previous 10 Next 10